EnvoyAI Partner:


Imbio Logo RGB_Vertical_Verticle.png
if_Laptop_B_104985.png
Website: www.imbio.com
if_290_279051.png
Year Founded: 2012
if_search_244366.png
Area of Focus/Speciality: Quantitative CT analysis of pulmonary tissue and diseases
if_hospital_clinic_133105.png
Hospital Associations: N/A
if__location_1964213.png
Company Headquarters: Minneapolis, MN
2538894-128.png
Number of Algorithms: 2
imbio linkedin page
imbio twitter profile

Imbio, LLC

About Imbio

TURNING MEDICAL IMAGES INTO LIFE-CHANGING INSIGHTS. With big data analytics and computer vision, Imbio transforms standard medical images into rich visual maps of patient conditions, and quantitative reports that provide physicians detailed data to enable more personalized care decisions. Imbio’s industry-leading suite of pulmonary analysis is fully-automated, delivering analysis results directly to the patient study in just minutes. By combining detailed AI analysis and time-saving automation, Imbio is changing healthcare for millions of patients with chronic lung conditions and the physicians who treat them.

if__location_1964213.png

Reference Sites:

  • Lung Density Analysis (LDA)
    • UPMC (Pittsburgh, PA)
    • Northwestern Medicine (Chicago, IL)
    • Froedtert & the Medical College of Wisconsin - (Milwaukee, WI)
    • University of Michigan
  • Lung Texture Analysis (LTA)
    • The University of Edinburgh (Edinburgh, Scotland)
Imbio Leadership
Alnawaz Rehemtulla Ph.D

Alnawaz Rehemtulla Ph.D

Co-Founder and Advisor

DANNY CUNAGIN

Danny Cunagin

Chief Executive Officer

DAVID HANNES

David Hannes

Chief Operating Officer

BRIAN ROSS, PH.D. CO-FOUNDER AND ADVISOR

Brian Ross, Ph.D.

Co-Founder and Advisor

Imbio Machine | Lung Density Analysis

Imbio is directly responsible for product and clinical representations

  • Report image_LDA Functional_Physician Report.png
  • Report image_LDA Inspiration_Patient LungMap Report.png
  • Report image_LDA Inspiration_Physician Report.png
  • Osirix screenshot_LDA (COPD subject).png
  • ImbioLungFunc.png

Post-processing of Chest CT scans for COPD analysis. The Imbio LDA analysis performs image segmentation, registration, thresholding, and tissue classification based on standard Chest CT image series. The outputs provided from each analysis are a full DICOM image series with intuitive RGB overlays on the patient scan to highlight abnormalities including areas potentially indicative of emphysema and air trapping helping increase diagnostic confidence. LDA also provides a physician summary report with detailed quantification to support more personalized, data-based diagnosis and care decisions.

  • Indication for use: The Imbio CT Lung Density AnalysisTM software provides reproducible CT values for pulmonary tissue, which is essential for providing quantitative support for diagnosis and follow up examinations. The Imbio CT Lung Density AnalysisTM software can be used to support the physician in the diagnosis and documentation of pulmonary tissue images (e.g. abnormalities) from CT thoracic datasets. 3D segmentation and isolation of sub-components, volumetric analysis, density evaluations and reporting tools are provided.
  • Regulatory Status: FDA cleared

Imbio Machine | Lung Texture Analysis

Imbio is directly responsible for product and clinical representations

  • Report image_LTA_Physician Report.png
  • Osirix Screenshot_LTA (IPF subject).png
  • ImbioLungTexture.png

Post-processing of Chest CT scans for pulmonary fibrosis and ILD’s. LTA applies advanced computer vision to transform a standard chest CT into a detailed map of the lung textures that are key to identifying ILD’s and other fibrotic conditions (normal, ground glass, reticular, honeycomb and hyperlucent). The outputs provided from each analysis are a full DICOM image series with intuitive texture overlays on the patient scan to highlight abnormalities and increase diagnostic confidence. LTA also provides a physician summary report with detailed quantification of the textures by lung region to enable data-based decisions for drug therapy, clinical procedures and other personalized patient care.

  • Indication for Use: The Imbio CT LTA Software uses CT density values of pulmonary tissue to provide quantitation and visualization in support of diagnosis. The Imbio CT LTA Software performs three-dimensional segmentation and classifies the lung voxels into typical radiological categories. Automated reports and color overlays of the analysis are provided to support diagnosis when abnormal lung parenchymal densities are present.
  • Regulatory Status: not FDA cleared